Gout in history of humanity
https://doi.org/10.47360/1995-4484-2024-254-261
Abstract
Gout has the richest history of all rheumatic diseases. The name of this most ancient of the described diseases of the musculoskeletal system for a long time not only determined the fact of damage to the joints, but was also synonymous with severe pain. Although the disease itself is much older than humanity and dates back to prehistoric times, it was with the advent of man on Earth that gout began to influence the historical process and became an integral part of it. Since ancient times, it was noticed that famous kings, emperors, generals, admirals and philosophers, musicians and artists, scientists and writers often suffered from gout. The cause of the disease was seen in a sedentary lifestyle, overeating, and abuse of wine with significant mental stress. And now it is difficult to imagine our world without this disease, which is so closely intertwined with the history of humanity.
About the Authors
M. S. Eliseev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Maxim S. Eliseev
115522, Moscow, Kashirskoye Highway, 34A
Ya. I. Kuzmina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Yanina I. Kuzmina
115522, Moscow, Kashirskoye Highway, 34A
E. L. Nasonov
V.A. Nasonova Research Institute of Rheumatology;
I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Evgeny L. Nasonov
115522, Moscow, Kashirskoye Highway, 34A,
119991, Moscow, Trubetskaya str., 8, building 2
References
1. Rothschild BM, Tanke D, Carpenter K. Tyrannosaurs suffered from gout. Nature. 1997;387(6631):357. doi: 10.1038/387357a0
2. Kratzer JT, Lanaspa MA, Murphy MN, Cicerchi C, Graves CL, Tipton PA, et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci U S A. 2014;111(10):3763-3768. doi: 10.1073/pnas.1320393111
3. Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34(1):78-84. doi: 10.1007/BF00163854
4. Johnson RJ, Andrews P, Benner SA, Oliver W. Theodore E. Woodward award. The evolution of obesity: Insights from the midMiocene. Trans Am Clin Climatol Assoc. 2010;121:295-308.
5. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858-6862. doi: 10.1073/pnas.78.11.6858
6. Schwartz SA. Disease of distinction. Explore (NY). 2006;2(6):515- 519. doi: 10.1016/j.explore.2006.08.007
7. Leatherwood C, Panush RS. Did King Herod suffer from a rheumatic disease? Clin Rheumatol. 2017;36(4):741-744. doi: 10.1007/s10067-017-3583-z
8. Pinals RS. The tale of a city saved by gout and a letter from Jesus. J Clin Rheum. 2008;14(4):247-248. doi: 10.1097/rhu.0b013e318181b4ad
9. Pinals RS, Schlesinger N. Did Michelangelo have gout? J Clin Rheumatol. 2015;21(7):364-367. doi: 10.1097/RHU.0000000000000301
10. Fornaciari G, Giuffra V. The “gout of the Medici”: Making the modern diagnosis using paleopathology. Gene. 2013;528(1):46- 50. doi: 10.1016/j.gene.2013.04.056
11. Verlaan JJ, Oner FC, Maat GJ. Diffuse idiopathic skeletal hyperostosis in ancient clergymen. Eur Spine J. 2007;16(8):1129-1135. doi: 10.1007/s00586-007-0342-x.
12. Littlejohn GO, Hall S. Diffuse idiopathic skeletal hyperostosis and new bone formation in male gouty subjects. A radiologic study. Rheumatol Int. 1982;2(2):83-86. doi: 10.1007/BF00541250
13. Bianucci R, Perciaccante A, Appenzeller O. “From father to son”: Early onset gout in Guidobaldo I da Montefeltro, Duke of Urbino (1472–1508). Eur J Internal Med. 2016;36:e28-e30. doi: 10.1016/j.ejim.2016.07.018
14. Liu YF, Wang HH, Geng YH, Han L, Tu SH, Chen JS, et al. Uncovering the potential mechanisms and effects of hyperuricemia and its associated diseases on male reproduction. Reprod Sci. 2024 Feb 20. doi: 10.1007/s43032-024-01453-7
15. Dittmar JM, Mitchell PD, Jones PM, Mulder B, Inskip SA, Cessford C, et al. Gout and ‘Podagra’ in medieval Cambridge, England. Int J Paleopathol. 2021;33:170-181. doi: 10.1016/j.ijpp.2021.04.007
16. Tabatabaei SM, Tabatabaei SM, Zamani MM, Sabetkish N, Roshani F. Rhazes viewpoints about causes, diagnosis, treatment and prognosis of gout. J Med Ethics Hist Med. 2012;(5):3.
17. Hartung EF. History of the use of colchicum and related medicaments in gout: With suggestions for further research. Ann Rheum Dis. 1954;13:190-200.
18. Pillinger MH, Rosenthal P, Abeles AM. Hyperuricemia and gout: New insights into pathogenesis and treatment. Bull NYU Hosp Jt Dis. 2007;65(3):215-221.
19. Nasonova VA, Zakharova MM, Barskova VG, Karateev AE, Fedorova AA, Yakunina IA, et al. Detection of sodium monourate crystals in biopsies of gastric mucosa in gout patients. Terapevticheskii arkhiv. 2004;79(6):47-51. (In Russ.).
20. Sydenham T. The works of Thomas Sydenham, MD translated by R.G. Latham. Vol. II. London:Sydenham Society;1848.
21. Nuki G. Treatment of crystal arthropathy – History and advances. Rheum Dis Clin North Am. 2006;32(2):333-357,vi. doi: 10.1016/j.rdc.2006.03.003
22. Buchanan WW, Kean WF. William Heberden the elder (1710– 1801): The compleat physician and sometime rheumatologist. Clin Rheumatol. 1987;6(2):251-263. doi: 10.1007/BF02201032
23. Nerlekar N, Beale A, Harper RW. Colchicine – A short history of an ancient drug. Med J Aust. 2014;201(11):687-688.
24. Garrod AB. The nature and treatment of gout and rheumatic gout. London:Walton and Maberly;1859.
25. Storey GD. Alfred Baring Garrod (1819–1907). Rheumatology (Oxford). 2001;40(10):1189-1190. doi: 10.1093/rheumatology/40.10.1189
26. Brill JM, McCarty DJ. “Studies on the nature of gouty tophi” by Max Freudweiler, 1899. (An inflammatory response to injected sodium urate, 1899). AN abridged translation, with comments. Ann Intern Med. 1964;60:486-505. doi: 10.7326/0003-4819-60-3-486
27. Ambrose J, Hounsfield G. Computerized transverse axial tomography. Br J Radiol. 1973;46(542):148-149.
28. Hounsfield GN. Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol. 1973;46(552):1016- 1022. doi: 10.1259/0007-1285-46-552-1016
29. Genant HK, Boyd D. Quantitative bone mineral analysis using dual energy computed tomography. Invest Radiol. 1977;12(6):545- 551. doi: 10.1097/00004424-197711000-00015
30. Flohr TG, McCollough CH, Bruder H, Petersilka M, Gruber K, Süss C, et al. First performance evaluation of a dual-source CT (DSCT) system. Eur Radiol. 2006;16(2):256-268. doi: 10.1007/s00330-005-2919-2
31. Choi HK, Al-Arfaj AM, Eftekhari A, Munk PL, Shojania K, Reid G, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis. 2009;68(10):1609-1612. doi: 10.1136/ard.2008.099713
32. Nicolaou S, Yong-Hing CJ, Galea-Soler S, Hou DJ, Louis L, Munk P. Dual-energy CT as a potential new diagnostic tool in the management of gout in the acute setting. Am J Roentgenol. 2010;194(4):1072-1078. doi: 10.2214/AJR.09.2428
Review
For citations:
Eliseev M.S., Kuzmina Ya.I., Nasonov E.L. Gout in history of humanity. Rheumatology Science and Practice. 2024;62(3):254-261. (In Russ.) https://doi.org/10.47360/1995-4484-2024-254-261
Views:
674
Email this article 